Skip to content

7 papers reviewed

Ovulation Support (Non-IVF)

2014 · RCT (multicenter, double-blind) · 1 of 7

Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome

Legro RS et al. · New England Journal of Medicine

In 750 women with PCOS, letrozole had higher cumulative live birth rate (27.5% vs 19.1%; RR 1.44) and ovulation rate (61.7% vs 48.3%) compared to clomiphene. Letrozole should be first-line for PCOS ovulation induction.

Read the paper ↗

2025 · narrative review · 2 of 7

Letrozole at the crossroads of efficacy and fetal safety in ovulation induction: a narrative review

Various · Cureus

Comprehensive review of letrozole for ovulation induction. Confirms efficacy while examining safety profile including low twin pregnancy rate (3% vs 7% for clomiphene).

Read the paper ↗

2020 · cohort · 3 of 7

Effect of HCG-triggered ovulation on pregnancy outcomes in intrauterine insemination: an analysis of 5,610 first IUI natural cycles

Various · Frontiers in Endocrinology

HCG-triggered ovulation improved clinical pregnancy (27.4% vs 22.7%) and live birth rates (24.5% vs 20.1%) compared to spontaneous LH surge in natural cycle IUI. Pregnancy rate increased by ~31% with trigger timing.

Read the paper ↗

2005 · meta-analysis · 4 of 7

Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis

Steiner AZ et al. · Human Reproduction

Tamoxifen and clomiphene are equally effective in inducing ovulation with similar pregnancy rates. No significant differences in luteal phase length or progesterone levels. Tamoxifen is a viable alternative.

Read the paper ↗

2014 · RCT · 5 of 7

Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation

Various · Reproductive Health

All three agents (clomiphene, tamoxifen, letrozole) effective for isolated anovulation. Letrozole showed advantages in endometrial thickness and lower multiple gestation risk.

Read the paper ↗

2021 · review · 6 of 7

Prospective of low dose naltrexone use in treatment of autoimmune pathology and endometriosis

Various · Reproductive Endocrinology

LDN (1.5-4.5mg) exhibits anti-inflammatory and immune-modulating properties. Allows pain/inflammation management while patient continues to ovulate regularly. Compatible with active conception attempts.

Read the paper ↗

1997 · meta-analysis · 7 of 7

Intrauterine insemination vs timed intercourse in superovulated cycles: a meta-analysis

Costello MF et al. · Fertility and Sterility

IUI shows better conception rates than timed intercourse in stimulated cycles overall, but timed intercourse increases pregnancy rate in patients with lower motile sperm count (<40 million).

Read the paper ↗

A paper's presence documents the evidence reviewed; it does not mean Filia endorses every intervention or conclusion.